About Cognos Therapeutics
Cognos Therapeutics is a company based in Los Angeles (United States) founded in 2015. It operates as a AI-as-a-Service, Product-as-a-Service, and HealthTech. Cognos Therapeutics has raised $5.75 million across 7 funding rounds. The company has 13 employees as of December 31, 2022. Cognos Therapeutics offers products and services including SINNAIS™ Implantable Smart Pump. Cognos Therapeutics operates in a competitive market with competitors including TriSalus Life Sciences, Impel NeuroPharma, CraniUS, Cooler Heads and Luminate Medical, among others.
- Headquarter Los Angeles, United States
- Employees 13 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cognos Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.75 M (USD)
in 7 rounds
-
Latest Funding Round
$55.25 K (USD), Series A
Oct 12, 2021
-
Investors
-
Employee Count
13
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cognos Therapeutics
Cognos Therapeutics offers a comprehensive portfolio of products and services, including SINNAIS™ Implantable Smart Pump. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
An AI-driven pump for precise brain drug delivery.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Cognos Therapeutics
Cognos Therapeutics has successfully raised a total of $5.75M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $55.25 thousand completed in October 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series A — $55,250
-
First Round
First Round
(07 Dec 2015)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2021 | Amount | Series A - Cognos Therapeutics | Valuation |
investors |
|
| Jul, 2021 | Amount | Series A - Cognos Therapeutics | Valuation |
investors |
|
| May, 2021 | Amount | Series A - Cognos Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Cognos Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cognos Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cognos Therapeutics Comparisons
Competitors of Cognos Therapeutics
Cognos Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TriSalus Life Sciences, Impel NeuroPharma, CraniUS, Cooler Heads and Luminate Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of drug delivery devices to treat cancers
|
|
| domain | founded_year | HQ Location |
Intranasal delivery technology for CNS diseases is developed.
|
|
| domain | founded_year | HQ Location |
Drug delivery systems for brain diseases and disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of cold cap system to prevent chemotherapy side effects
|
|
| domain | founded_year | HQ Location |
Developer of a medical device to prevent hair loss during chemotherapy
|
|
| domain | founded_year | HQ Location |
Catheter-based system for localized cancer therapy is being developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cognos Therapeutics
Frequently Asked Questions about Cognos Therapeutics
When was Cognos Therapeutics founded?
Cognos Therapeutics was founded in 2015.
Where is Cognos Therapeutics located?
Cognos Therapeutics is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Who is the current CEO of Cognos Therapeutics?
Frank Adell is the current CEO of Cognos Therapeutics.
Is Cognos Therapeutics a funded company?
Cognos Therapeutics is a funded company, having raised a total of $5.75M across 7 funding rounds to date. The company's 1st funding round was a Series A of $3.82M, raised on Dec 07, 2015.
How many employees does Cognos Therapeutics have?
As of Dec 31, 2022, the latest employee count at Cognos Therapeutics is 13.
What does Cognos Therapeutics do?
Cognos Therapeutics, Inc. is engaged in the development and commercialization of advanced medical products integrating diagnostic, therapeutic, and sensing technologies. Emphasis is placed on AI and blockchain-driven solutions for drug delivery, particularly through the SINNAIS implantable smart pump. The company targets unmet needs in neurodegenerative diseases like Alzheimers and various cancers, including glioblastoma and pancreatic cancer. Solutions are designed to overcome barriers such as the blood-brain barrier, addressing significant healthcare challenges. Operations span sectors like healthcare and biotechnology, with a focus on improving patient outcomes through precise, technology-enhanced treatments.
Who are the top competitors of Cognos Therapeutics?
Cognos Therapeutics's top competitors include TriSalus Life Sciences, Cooler Heads and Impel NeuroPharma.
What products or services does Cognos Therapeutics offer?
Cognos Therapeutics offers SINNAIS™ Implantable Smart Pump.